Evaluating the Hematological Parameter Alterations Induced by Mavyret in Chronic Hepatitis Patients
<b>Background/Objectives</b>: The hepatitis C virus (HCV) is a significant threat to people with persistent infections. In recent years, the treatment of chronic hepatitis C (CHC) has been transformed significantly with the use of Direct-Acting Antivirals (DAAs). Hematological changes ar...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-10-01
|
Series: | Gastrointestinal Disorders |
Subjects: | |
Online Access: | https://www.mdpi.com/2624-5647/6/4/58 |